Can FDG-PET/CT Predict Early Response to Neoadjuvant Chemotherapy in Breast Cancer?
W.P. Andrade, E.N.P. Lima, C.A.B.T. Osorio, M. do Socorro Maciel, G. Baiocchi, A.G.V. Bitencourt, M.F. Fanelli, A.S. Damascena and F.A. Soares | 23.08.2013
The study correlates the relative change in SUV of 18F FDG PET/CT with pathologic response post neoadjuvent chemotherapy (NAC). The data suggests that the second course of NAC can improve therapy decision making.